approval
saveABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval
community read0 votes
Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalARIPIPRAZOLE — FDA approvalFeb 18, 2026 · 226d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJan 28, 2026 · 247d ago
- approvalARIPIPRAZOLE — FDA approvalOct 22, 2025 · 345d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalMar 28, 2025 · 553d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJan 22, 2025 · 618d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalFeb 5, 2020 · 2431d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalJul 27, 2017 · 3354d ago
- approvalABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalFeb 23, 2017 · 3508d ago
comments(0)
5-min edit window · permanent after that